How has the primary cell culture market evolved, and where is it heading next?
The primary cell culture market size has grown rapidly in recent years. It will grow from $6.79 billion in 2024 to $7.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing demand for monoclonal antibodies, increased demand for novel therapeutics, growing demand for personalized medicine, growing demand in cell therapy research.
The primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $13.65 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rapid growth in incidence of cancer, rising growth in pharmaceutical and biotechnology industries, growing demand for personalized medicine, growing applications in 3D cell culture models. Major trends in the forecast period include technological advancements,product innovation, partnerships, research and development.
Get Your Free Sample of The Global Primary Cell Culture Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15903&type=smp
What have been the primary factors driving the primary cell culture market’s growth?
The increasing prevalence of chronic diseases is expected to propel the growth of the primary cell culture market going forward. Chronic diseases are long-lasting conditions that typically progress slowly and persist for long, often for the remainder of an individual’s life. The rise in chronic diseases can be attributed to various factors, including lifestyle changes, environmental influences, physical inactivity, dietary shifts, and demographic shifts. Primary cell cultures significantly advance knowledge and treatment strategies for chronic diseases, ultimately improving patient outcomes. For instance, in January 2023, according to the National Center For Biotechnology Information, a US-based government agency, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the increasing prevalence of chronic diseases drives the primary cell culture market.
What are the key segments within the primary cell culture market?
The primary cell culture market covered in this report is segmented –
1) By Product: Primary Cell, Reagents, Supplements, Media
2) By Cell Type: Animal Cells, Human Cells
3) By Separation And culture Techniques: Explant Method, Enzymatic Disaggregation, Mechanical Separation, Other Separation
4) By Application: Tissue Culture and Tissue Engineering, Vaccine Production, Gene Therapy And Regenerative Medicine, Drug Screening And Toxicity Testing, Cancer Research, Virology, Strem Cell Therapy, Other Applications
5) By End User: Pharmaceutical And Biotechnology Company And Contract Research Organizations, Academic And Research Institutes, Other End Users
Subsegments:
1) By Primary Cell: Human Primary Cells, Animal Primary Cells
2) By Reagents: Enzymes, Buffers And Salts, Antibodies
3) By Supplements: Growth Factors, Serum Supplements, Hormones
4) By Media: Basal Media, Serum-Free Media, Specialty Media
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report
Which key players are shaping the primary cell culture market?
Major companies operating in the primary cell culture market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sàrl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies
How will emerging trends drive the primary cell culture market throughout the forecast period?
Major companies operating in the primary cell culture market are developing cell banks that contain primary cells specifically for cultivated meat research, aiming to advance sustainable and ethical meat production technologies. The Cell Bank initiative aims to support early-stage companies and researchers by providing high-quality animal primary cells suitable for cultivated meat research and development, up to 90% cheaper than other cell line providers, and free from licensing restrictions. For instance, in June 2023, Extracellular, a UK-based CDMO (contract development and manufacturing organization), launched low-cost, license-free cell banks to support the cultivated meat sector. The cell banks initially offer cells isolated from cows, pigs, and lambs’ fat, muscle, and bone marrow tissues. This project demonstrates a collaborative approach to accelerate the growth of the cultivated meat industry in the UK by increasing the availability of cell lines and enabling researchers and companies to develop innovative technologies without restrictions from licensing or commercial agreements.
How do regional factors impact the primary cell culture market, and which region is the largest contributor?
North America was the largest region in the primary cell culture market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Primary Cell Culture Market Report 2025 Offer?
The primary cell culture market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Primary cell culture refers to the process of isolating cells directly from a tissue or organism and growing them in a controlled laboratory environment. The process involves obtaining tissues from a human or animal, disaggregating them using various methods, and inducing the viable cells to grow in culture vessels with specialized media.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15903
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
